Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

Study Purpose

The goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Interventional
Eligible Ages 40 Years - 75 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

1. Willing and able to provide informed consent. 2. Male or female aged 40-75. 3. Being seen by a dermatology provider in routine care for the primary encounter diagnosis of psoriasis.

Exclusion Criteria:

1. Currently taking a prescription lipid lowering medication. 2. Pregnant or planning pregnancy in the next 6 months. 3. Has a known history of cardiovascular disease (MI, Stroke, coronary artery, cerebrovascular, or peripheral vascular disease)

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT05908240
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

N/A
Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

University of Pennsylvania
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

N/A
Principal Investigator Affiliation N/A
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other
Overall Status Recruiting
Countries United States
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Psoriasis, Psoriatic Arthritis, Psoriatic Conditions, Cardiovascular Diseases
Additional Details

Psoriasis patients have an increased risk of cardiovascular disease and mortality but are less likely to have traditional cardiovascular risk factors identified or adequately managed. Care coordinators have previously been demonstrated to improve outcomes in patients with chronic diseases (such as comorbid diabetes and depression) and are now routinely embedded in primary care practices in integrated health systems. The goal of this research is to test a novel centralized care coordinator program to assist patients with psoriatic disease in lowering their risk of cardiovascular disease through the application of standard of care approaches to improving modifiable cardiovascular risk factors.

Arms & Interventions

Arms

Other: Care Coordination

Interventions

Other: - Care Coordinator Model

A centralized care coordinator at the National Psoriasis Foundation will provide evidence-based education regarding a heart healthy lifestyle (i.e., diet, exercise, smoking cessation) and guidance from the American Heart Association/American College of Cardiology regarding management of dyslipidemia and hypertension. This information will be conveyed to a primary care provider of the patient's preference.

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

Johnson Dermatology, Fort Smith 4111410, Arkansas 4099753

Status

Recruiting

Address

Johnson Dermatology

Fort Smith 4111410, Arkansas 4099753, 72916

Site Contact

Karen Garduza

[email protected]

267-581-9714

Dawes Fretzin Clinical Research, Columbus 4256038, Indiana 4921868

Status

Recruiting

Address

Dawes Fretzin Clinical Research

Columbus 4256038, Indiana 4921868, 47201

Site Contact

Betty Uyesugi

[email protected]

267-581-9714

Dawes Fretzin Clinical Research, Indianapolis 4259418, Indiana 4921868

Status

Recruiting

Address

Dawes Fretzin Clinical Research

Indianapolis 4259418, Indiana 4921868, 46250

Site Contact

Ashley Wallace

[email protected]

267-581-9714

MiSkinCenter, Northville 5003956, Michigan 5001836

Status

Recruiting

Address

MiSkinCenter

Northville 5003956, Michigan 5001836, 48167

Site Contact

Jamie Szkodzinski

[email protected]

267-581-9714

SUNY Downstate, Brooklyn 5110302, New York 5128638

Status

Recruiting

Address

SUNY Downstate

Brooklyn 5110302, New York 5128638, 11203

Site Contact

Tristi Edwards

[email protected]

267-581-9714

City Dermatology, Bensalem 5179995, Pennsylvania 6254927

Status

Recruiting

Address

City Dermatology

Bensalem 5179995, Pennsylvania 6254927, 19020

Site Contact

Arslan Amir

[email protected]

267-581-9714

University of Pennsylvania, Philadelphia 4560349, Pennsylvania 6254927

Status

Recruiting

Address

University of Pennsylvania

Philadelphia 4560349, Pennsylvania 6254927, 19104

Site Contact

Brooke Bishop, MPH

[email protected]

267-581-9714

University of Utah, Salt Lake City 5780993, Utah 5549030

Status

Recruiting

Address

University of Utah

Salt Lake City 5780993, Utah 5549030, 84112

Site Contact

Isaac Goddard

[email protected]

267-581-9714

University of Virginia, Charlottesville 4752031, Virginia 6254928

Status

Recruiting

Address

University of Virginia

Charlottesville 4752031, Virginia 6254928, 22903

Site Contact

Lauren Khuns

[email protected]

267-581-9714

Bellevue Dermatology Clinic, Bellevue 5786882, Washington 5815135

Status

Recruiting

Address

Bellevue Dermatology Clinic

Bellevue 5786882, Washington 5815135, 98004

Site Contact

Emily Leung

[email protected]

267-581-9714